Enjoying this newsletter? Know someone who would too? Forward this email to them!
Sign up (it’s free)

🇺🇸 US researchers create first scalable quantum system to suppress errors below critical threshold

A Harvard- and MIT-led team has built a 448-qubit system that successfully corrects quantum errors below the threshold needed for fault-tolerant computing - marking a major leap toward practical quantum supercomputers. Using rubidium atoms, the system integrates key quantum techniques like logical entanglement and teleportation to achieve an architecture that improves with scale. Published in Nature, the breakthrough by Harvard, MIT, and partners such as QuEra and NIST demonstrates the first conceptually scalable error-corrected quantum system.

🇨🇳 Chinese firm begins world’s first large-scale humanoid robot delivery for factory work

Shenzhen-based UBTECH Robotics has launched the world’s first mass delivery of humanoid robots, sending hundreds of its Walker S2 units to industrial customers across China. The robots are designed for continuous manual tasks in factories and warehouses, with a self-swapping battery system that enables 24-hour operation without human intervention. Backed by major clients like BYD, Geely, and Foxconn, the rollout marks a turning point for humanoid deployment beyond labs, driven by over 800 million yuan in 2025 orders.

🇺🇸 US researchers use robotic exoskeleton to detect stroke-related sensory deficits clinicians rarely test

A team at the University of Delaware has developed a robotic exoskeleton system that reveals hidden proprioceptive deficits - loss of the body’s sense of limb position - in stroke survivors, a condition that only 1% of clinicians currently test for. Published in Neurorehabilitation and Neural Repair, the system isolates sensory loss from motor issues, allowing accurate assessments even when patients can’t move their affected limbs. The breakthrough may reshape stroke rehab by emphasizing the sensory system’s critical role in recovery.

Nanalyze, our go-to source for no-BS investment analysis on disruptive tech, released the following interesting pieces this week:

The Hidden Flaw Dooming OKLO & Nuclear Stocks in 2026

Did You Start Investing Too Late? Don’t Worry! Here’s Why.

NextEra Energy Looks to Solve AI Energy Crisis

Alarm.com Shows Smart Homes Are Saturated

🇺🇸 US inventors develop soda-inspired tech that captures 99% of CO₂ at record-low cost

Researchers from Texas A&M University and ExcelThermic Enterprises have created a water-based carbon capture system called Pressure Induced Carbon Capture (PICC) that removes 99% of CO₂ from industrial emissions for just $26 per ton. Inspired by the way carbon dioxide dissolves and releases in fizzy drinks, the method avoids expensive chemicals and instead uses pressure changes to absorb and release CO₂. The scalable system works across power plants and heavy industry, and adding lime enables full 100% capture, including atmospheric CO₂, at only $28 per ton.

🇨🇳 Chinese scientists gene-edit fungus into meat-like protein with 60% lower emissions and 70% less land use

Researchers at Jiangnan University have used CRISPR to modify Fusarium venenatum, creating a more digestible, meat-like fungus that cuts greenhouse gas emissions by 60% and land use by 70% compared to chicken. The gene-edited strain, detailed in Trends in Biotechnology, requires 44% less sugar and grows 88% faster, offering a scalable, low-impact alternative to animal farming and traditional mycoproteins.

🇳🇱 Dutch startup nears commercial rollout of carbon-to-stone tech after 2,500-hour operation milestone

Netherlands-based Paebbl has completed over 2,500 hours of continuous operation at its pilot and demo plants, proving its carbon mineralization process can rapidly lock CO₂ into stone-like materials at near-industrial scale. The tech, which mimics natural processes in hours instead of centuries, uses AI systems and digital twins to accelerate development and reduce costs. With demand rising from the construction sector, the company is preparing to launch its first commercial-scale facility.

🇨🇭 Swiss researchers build first lab-grown human bone marrow to replace animal testing and aid cancer research

Bioengineers from the University of Basel and University Hospital Basel have created the first fully human bone marrow model in the lab, using stem cells and an artificial bone scaffold to replicate the complex blood-producing endosteal niche. This 3D “blood factory,” detailed in Cell Stem Cell, sustains blood formation for weeks and could reduce reliance on animal testing while advancing drug screening and personalized cancer treatment.

That’s all for today, please reply to this email if you have any comments or feedback, we’d love to hear from you about what we can do better!

Have you enjoyed this email? Make sure to share it with your friends and colleagues.

See you soon,

Max

Subscribe (it’s free)